ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1063

Spirulina Stimulates Inflammatory Cytokine Production Through the STING and TLR Pathways in Dermatomyositis in Vitro

Christina Bax1, Yubin Li1, Spandana Maddukuri2, Adarsh Ravishankar3, Jay Patel3, Daisy Yan1, Josef Symon Concha1 and Victoria Werth1, 1University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Philadelphia, PA, 2University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Montville, NJ, 3University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Philadelphia

Meeting: ACR Convergence 2020

Keywords: Autoinflammatory diseases, cytokines, Dermatology, dermatomyositis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Muscle Biology, Myositis & Myopathies Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Spirulina, a popular herbal supplement, stimulates the immune system, as determined by in vitro and in vivo studies. Our recent epidemiologic data suggest that Spirulina is associated with the onset or exacerbation of pre-existing autoimmune skin diseases, such as DM. The purpose of this study was to investigate the immunostimulatory effects of Spirulina and characterize the role of the Stimulator of interferon genes (STING) and Toll-like Receptor (TLR) pathways.

Methods: PBMCs were isolated from DM and normal controls and stimulated with increasing concentrations of pure Spirulina supernatant (0, 0.3, and 1 mg/ml). All DM patients met the EULAR/ACR definition of DM or amyopathic DM. PBMCs were also pre-treated for 1 hour with the following inhibitors: STING inhibitor, H-151; TLR4 inhibitor, TAK 242; TLR2 and TLR4 inhibitor, Sparstolonin B; and TBK1 inhibitor, MRT67307. Cells were incubated for 18 hours before supernatant was collected for ELISA.  

Results: Spirulina dose-dependently increases PBMC production of IFNβ in DM patients (Figure 1a). Spirulina also increases PBMC production of TNFα, with peak levels when stimulated with 0.3 mg/ml Spirulina (Figure 1b).

In the presence of Spirulina, STING inhibitor suppressed secretion of IFNβ in all five DM patients. “Good Responders,” defined as subjects with >20% decrease in cytokine levels with STING inhibitor and stimulation at both Spirulina concentrations had mean (standard error of mean) IFNβ levels of 33.78 (1.51) pg/ml pre-antagonist and 13.19 (7.11) post-antagonist when stimulated with Spirulina 0.3 mg/ml and IFNβ levels of 59.47 (7.04) pg/ml pre-antagonist and 33.81 (8.17) post-antagonist when stimulated with Spirulina 1 mg/ml (p=0.06) (Figure 2).

With Spirulina stimulation, STING inhibitor only suppressed secretion of TNFα in 6/15 subjects and these results were not statistically significant. A second experiment using 3 subjects further examined the effects of TLR2 and TLR4, TLR2 and TLR4 and STING, TBK1, or TLR4 inhibition on PBMC production of TNFα. In the presence of 0.3 mg/ml Spirulina stimulation, these four inhibitors significantly decreased TNFα levels (Figure 3) with TNFα decreasing from mean (standard error of mean) 1829 (243.47) pg/ml to 384.6 (149.27), 346.0 (138.11) 410.7 (73.43), and 175.7 (17.68) pg/ml when TLR2 and TLR4, TLR2 and TLR4 and STING, TBK1, or TLR4 inhibitors were added, respectively (n=3) (p< 0.0001). STING inhibition decreased TNFα production from 1829 pg/ml to 1488 pg/ml (n=3) (p=0.84).

Conclusion: Our preliminary results show that Spirulina increases production of key inflammatory cytokines TNFα and IFNβ. For TNFα production, Spirulina’s immunostimulatory effects appear to be primarily mediated via the TLR4 pathway. Inhibition of TBK1, an important kinase in the innate immune system active in both the STING and NF-kappa B pathways, also significantly decreases TNFα production. For IFNβ production, Spirulina’s immunostimulatory effects appear to be partially mediated by the STING pathway. Our findings provide a potential mechanism by which Spirulina use may lead to disease onset or flare in susceptible patients.

Figure 1. (a) DM PBMCs secreted mean (standard error of mean) IFNβ of 14.18 (4.18), 38.26 (4.69), and 97.42 (23.76) pg/ml, at 0, 0.3, and 1 mg/ml Spirulina concentrations, respectively (n=6). (b) DM PBMCs secreted mean (standard error of mean) TNFα of 213.03 (101.08), 1718.94 (208.95), and 938.36 (134.72) pg/ml at 0, 0.3, and 1 mg/ml Spirulina concentrations, respectively (n=17). Bars show * p < 0.05, ** p < 0.01, **** p < 0.0001. Line represents the median.

Figure 2. Effects of STING inhibitor versus sham on secretion of IFNβ from unstimulated and Spirulina-stimulated PBMCs in “Good Responders.” Line represents the median. (n=3)

Figure 3. Effects of STING, TLR2 + TLR4, TLR2 + TLR4 + STING, TBK1, or TLR4 inhibition versus sham on secretion of TNFα from unstimulated and Spirulina-stimulated PBMCs (n=3). Bars show **** p < 0.0001. Line represents the median.


Disclosure: C. Bax, National Center for Advancing Translational Sciences of the National Institutes of Health, 2; Y. Li, None; S. Maddukuri, None; A. Ravishankar, None; J. Patel, None; D. Yan, None; J. Concha, None; V. Werth, Biogen, 2, 5.

To cite this abstract in AMA style:

Bax C, Li Y, Maddukuri S, Ravishankar A, Patel J, Yan D, Concha J, Werth V. Spirulina Stimulates Inflammatory Cytokine Production Through the STING and TLR Pathways in Dermatomyositis in Vitro [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/spirulina-stimulates-inflammatory-cytokine-production-through-the-sting-and-tlr-pathways-in-dermatomyositis-in-vitro/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spirulina-stimulates-inflammatory-cytokine-production-through-the-sting-and-tlr-pathways-in-dermatomyositis-in-vitro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology